Literature DB >> 7900896

Viscoelastic properties of cross bridges in cardiac muscle.

M E De Winkel1, T Blangé, B W Treijtel.   

Abstract

Tension responses of rat right ventricular trabeculae to fast length changes are measured with microsecond resolution to obtain information about elastic properties of ventricular myocardium. Responses of these isometrically mounted trabeculae at 22 degrees C to fast length changes completed within 30 microseconds at 22 degrees C to fast length changes completed within 30 microseconds were similar in shape to those of skeletal muscle fibers. Results of quantitative evaluation of responses are interpreted in terms of cross-bridge properties. An upper bound for the elastic range of cross bridges in trabeculae, derived from the maximal developed force during Ca2+ activation and from stiffness in rigor, has been estimated as 8.4 +/- 2.2 nm. Their working stroke, estimated from the tension loss in the rigor state due to a shortening and from tension remaining after (partial) recovery, was 20 +/- 4 nm. The estimated working stroke of cross bridges is about three times larger in trabeculae than in freeze-dried skeletal muscle fibers of the frog at 4 degrees C, which points to important differences between cross-bridge mechanisms of contraction in cardiac and skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7900896     DOI: 10.1152/ajpheart.1995.268.3.H987

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Size and speed of the working stroke of cardiac myosin in situ.

Authors:  Marco Caremani; Francesca Pinzauti; Massimo Reconditi; Gabriella Piazzesi; Ger J M Stienen; Vincenzo Lombardi; Marco Linari
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-16       Impact factor: 11.205

2.  Dexrazoxane pre-treatment protects skinned rat cardiac trabeculae against delayed doxorubicin-induced impairment of crossbridge kinetics.

Authors:  Evert L de Beer; Antonio E Bottone; Maartje C van Rijk; Jolanda van der Velden; Emile E Voest
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.